ctPath: Demixing pathway crosstalk effect from transcriptomics data for differential pathway identification
Tài liệu tham khảo
Zhang, 2013, Integrating genomic, epigenomic, and transcriptomic features reveals modular signatures underlying poor prognosis in ovarian cancer, Cell Rep., 4, 542, 10.1016/j.celrep.2013.07.010
Natrajan, 2013, From integrative genomics to therapeutic targets, Cancer Res., 73, 3483, 10.1158/0008-5472.CAN-12-4717
TCGA, Comprehensive Molecular Characterization of Human Colon and Rectal Cancer, Nature 487 (2012) 330–337.
Jiao, 2014, A systems-level integrative framework for genome-wide DNA methylation and gene expression data identifies differential gene expression modules under epigenetic control, Bioinformatics, 30, 2360, 10.1093/bioinformatics/btu316
Hu, 2013, Identifying novel glioma associated pathways based on systems biology level meta-analysis, BMC Syst. Biol., 7, S9, 10.1186/1752-0509-7-S2-S9
Downward, 2006, Signatures guide drug choice, Nature, 439, 274, 10.1038/439274a
D.N. Saunders, K.J. Falkenberg, K.J. Simpson, High-throughput approaches to measuring cell death, Cold Spring Harbor Protocols, 2014, pdb.top072561.
Chen, 2012, Personal omics profiling reveals dynamic molecular and medical phenotypes, Cell, 148, 1293, 10.1016/j.cell.2012.02.009
Schweizer, 2013, Enhancing cancer drug discovery through novel cell signaling pathway panel strategy, Cancer Growth Metas., 6, 53
Hansen, 2013, Computation as the mechanistic bridge between precision medicine and systems therapeutics, Clin. Pharmacol. Ther., 93, 117, 10.1038/clpt.2012.199
Goeman, 2007, Analyzing gene expression data in terms of gene sets: methodological issues, Bioinformatics, 23, 980, 10.1093/bioinformatics/btm051
Ramanan, 2012, Pathway analysis of genomic data: concepts, methods, and prospects for future development, Trends Gen.: TIG, 28, 323, 10.1016/j.tig.2012.03.004
Khatri, 2012, Ten years of pathway analysis: current approaches and outstanding challenges, PLoS Comput. Biol., 8, e1002375, 10.1371/journal.pcbi.1002375
Hosack, 2003, Identifying biological themes within lists of genes with EASE, Genome Biol., 4, R70, 10.1186/gb-2003-4-10-r70
Subramanian, 2005, Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles, Proc. Natl. Acad. Sci. U.S.A., 102, 15545, 10.1073/pnas.0506580102
Tian, 2005, Discovering statistically significant pathways in expression profiling studies, Proc. Natl. Acad. Sci. U.S.A., 102, 13544, 10.1073/pnas.0506577102
B. Efron, R. Tibshirani, On Testing the Significance of Sets of Genes, 2007, pp. 107–129.
Wang, 2011, SLIM: a sliding linear model for estimating the proportion of true null hypotheses in datasets with dependence structures, Bioinformatics, 27, 225, 10.1093/bioinformatics/btq650
Glazko, 2009, Unite and conquer: univariate and multivariate approaches for finding differentially expressed gene sets, Bioinformatics, 25, 2348, 10.1093/bioinformatics/btp406
Nettleton, 2008, Identification of differentially expressed gene categories in microarray studies using nonparametric multivariate analysis, Bioinformatics, 24, 192, 10.1093/bioinformatics/btm583
Mitrea, 2013, Methods and approaches in the topology-based analysis of biological pathways, Front. Physiol., 4, 10.3389/fphys.2013.00278
Hummel, 2008, GlobalANCOVA: exploration and assessment of gene group effects, Bioinformatics, 24, 78, 10.1093/bioinformatics/btm531
Martini, 2013, Along signal paths: an empirical gene set approach exploiting pathway topology, Nucl. Acids Res., 41, e19, 10.1093/nar/gks866
Liu, 2013, Topologically inferring risk active pathways toward precise cancer classification by directed random walk, Bioinformatics, 10.1093/bioinformatics/btt373
Glaab, 2013, EnrichNet: network-based gene set enrichment analysis, Bioinformatics, 28, i451, 10.1093/bioinformatics/bts389
Jacob, 2012, More power via graph-structured tests for differential expression of gene networks, Ann. Appl. Stat., 6, 561, 10.1214/11-AOAS528
Tarca, 2009, A novel signaling pathway impact analysis, Bioinformatics, 25, 75, 10.1093/bioinformatics/btn577
Chasman, 2014, Pathway connectivity and signaling coordination in the yeast stress-activated signaling network, Mol. Syst. Biol., 10, 759, 10.15252/msb.20145120
Edelman, 2008, Modeling cancer progression via pathway dependencies, PLoS Comput Biol., 4, e28, 10.1371/journal.pcbi.0040028
Lee, 1999, Learning the parts of objects by non-negative matrix factorization, Nature, 401, 788, 10.1038/44565
Brunet, 2004, Metagenes and molecular pattern discovery using matrix factorization, Proc. Natl. Acad. Sci. U.S.A., 101, 4164, 10.1073/pnas.0308531101
Zheng, 2011, Tumor classification based on non-negative matrix factorization using gene expression data, IEEE Trans. Nanobiosci., 10, 86, 10.1109/TNB.2011.2144998
Kim, 2007, Sparse non-negative matrix factorizations via alternating non-negativity-constrained least squares for microarray data analysis, Bioinformatics, 23, 1495, 10.1093/bioinformatics/btm134
Zhang, 2012, Discovery of multi-dimensional modules by integrative analysis of cancer genomic data, Nucl. Acids Res., 40, 9379, 10.1093/nar/gks725
Yuvaraj, 2013, An efficient svm based tumor classification with symmetry non-negative matrix factorization using gene expression data, 761
Wang, 2015, jNMFMA: a joint non-negative matrix factorization meta-analysis of transcriptomics data, Bioinformatics, 31, 572, 10.1093/bioinformatics/btu679
Smyth, 2004, Linear models and empirical bayes methods for assessing differential expression in microarray experiments, Stat. Appl. Genet. Mol. Biol., 3, 10.2202/1544-6115.1027
Hong, 2006, RankProd: a bioconductor package for detecting differentially expressed genes in meta-analysis, Bioinformatics, 22, 2825, 10.1093/bioinformatics/btl476
Wang, 2006, Regulation probability method for gene selection, Patt. Recogn. Lett., 27, 116, 10.1016/j.patrec.2005.07.007
Fang, 2014, An integrative gene selection with association analysis for microarray data classification, Intell. Data Anal., 18, 739, 10.3233/IDA-140666
Wang, 2007, Extracting gene regulation information for cancer classification, Patt. Recogn., 40, 3379, 10.1016/j.patcog.2007.04.007
Sartor, 2009, LRpath: a logistic regression approach for identifying enriched biological groups in gene expression data, Bioinformatics, 25, 211, 10.1093/bioinformatics/btn592
Han, 2015, ESEA: discovering the dysregulated pathways based on edge set enrichment analysis, Sci. Rep., 5, 13044, 10.1038/srep13044
Selamat, 2012, Genome-scale analysis of DNA methylation in lung adenocarcinoma and integration with mRNA expression, Genome Res., 22, 1197, 10.1101/gr.132662.111
Landi, 2008, Gene expression signature of cigarette smoking and its role in lung adenocarcinoma development and survival, PLoS ONE, 3, e1651, 10.1371/journal.pone.0001651
Su, 2007, Selection of DDX5 as a novel internal control for Q-RT-PCR from microarray data using a block bootstrap re-sampling scheme, BMC Genom., 8, 140, 10.1186/1471-2164-8-140
Cappello, 2014, Role of Nek2 on centrosome duplication and aneuploidy in breast cancer cells, Oncogene, 33, 2375, 10.1038/onc.2013.183
Catanzaro, 2014, Oncogenic ras induces inflammatory cytokine production by upregulating the squamous cell carcinoma antigens SerpinB3/B4, Nat. Commun., 5, 10.1038/ncomms4729
Zohrabian, 2009, Rho/ROCK and MAPK signaling pathways are involved in glioblastoma cell migration and proliferation, Anticancer Res., 29, 119
Chiu, 2007, Pathway aberrations of murine melanoma cells observed in Paired-End diTag transcriptomes, BMC Cancer, 7, 109, 10.1186/1471-2407-7-109
Dyke, 2009, Cytokine and cytokine receptor single-nucleotide polymorphisms predict risk for non-small cell lung cancer among women, Cancer Epidemiol. Biomark. Prevent., 18, 1829, 10.1158/1055-9965.EPI-08-0962
Ece, 2005, Does Helicobacter pylori infection play a role in lung cancer?, Respiratory Med., 99, 1258, 10.1016/j.rmed.2005.02.038
Deng, 2013, Helicobacter pylori infection and lung cancer: a review of an emerging hypothesis, Carcinogenesis, 34, 1189, 10.1093/carcin/bgt114
Berger, 2002, The mechanisms of action of PPARs, Ann. Rev. Med., 53, 409, 10.1146/annurev.med.53.082901.104018
Feige, 2006, From molecular action to physiological outputs: peroxisome proliferator-activated receptors are nuclear receptors at the crossroads of key cellular functions, Prog. Lipid Res., 45, 120, 10.1016/j.plipres.2005.12.002
Theocharis, 2002, Expression of peroxisome proliferator activated receptor-gamma in non-small cell lung carcinoma: correlation with histological type and grade, Lung Cancer, 36, 249, 10.1016/S0169-5002(02)00013-2
Sasaki, 2002, Decreased perioxisome proliferator-activated receptor gamma gene expression was correlated with poor prognosis in patients with lung cancer, Lung Cancer, 36, 71, 10.1016/S0169-5002(01)00449-4
Hazra, 2008, The role of PPARr in the cyclooxygenase pathway in lung cancer, PPAR Res., 2008, 7, 10.1155/2008/790568
Bren-Mattison, 2008, Antitumorigenic effects of peroxisome proliferator-activated receptor-r in non-small-cell lung cancer cells are mediated by suppression of cyclooxygenase-2 via inhibition of nuclear factor-kB, Mol. Pharmacol., 73, 709, 10.1124/mol.107.042002
Wick, 2002, Peroxisome proliferator-activated receptor-r is a target of nonsteroidal anti-inflammatory drugs mediating cyclooxygenase-independent inhibition of lung cancer cell growth, Mol. Pharmacol., 62, 1207, 10.1124/mol.62.5.1207
Kowanetz, 2006, Vascular endothelial growth factor signaling pathways: therapeutic perspective, Clin. Cancer Res.: Off. J. Am. Assoc. Cancer Res., 12, 5018, 10.1158/1078-0432.CCR-06-1520
Cramer, 1989, Galactose consumption and metabolism in relation to the risk of ovaran cancer, Lancet, 334, 66, 10.1016/S0140-6736(89)90313-9
Hirata, 2009, Wnt antagonist gene DKK2 is epigenetically silenced and inhibits renal cancer progression through apoptotic and cell cycle pathways, Clin. Cancer Res., 15, 5678, 10.1158/1078-0432.CCR-09-0558
Carnero, 2000, Cell cycle and cancer, Clin. Trans. Oncol., 2, 12
Teschendorff, 2014, The dynamics of DNA methylation covariation patterns in carcinogenesis, PLoS Comput. Biol., 10, e1003709, 10.1371/journal.pcbi.1003709
Sacerdote de Lustig, 1980, Association of chagas disease and cancer, Medicina, 40, 43
Marret, 2012, Therapeutic management of uterine fibroid tumors: updated French guidelines, Euro. J. Obst. Gynecol. Reprod. Biol., 165, 156, 10.1016/j.ejogrb.2012.07.030
Waning, 2013, Cancer-associated osteoclast differentiation takes a good look in the miR(NA)ror, Cancer Cell, 24, 407, 10.1016/j.ccr.2013.10.001
http://www.kegg.jp/pathway/hsa05210.
Scasso, 1998, Tuberculosis and cancer, Biomed. Pharmacother., 52, 346, 10.1016/S0753-3322(98)80128-5
Freedman, 2013, The association between cancer and amyotrophic lateral sclerosis, Cancer Caus. Control, 24, 55, 10.1007/s10552-012-0089-5
Haran, 2012, Cardiac mass and hypertrophic cardiomyopathy as aggressive presentation of primary cardiac lymphoma: a case report, J. Cancer Therapy, 03, 183, 10.4236/jct.2012.33026
Kotera, 2012, GENIES: gene network inference engine based on supervised analysis, Nucl. Acids Res., 10.1093/nar/gks459